Rural HEART Camp Connect: A Feasibility Study

Sponsor
University of Nebraska (Other)
Overall Status
Recruiting
CT.gov ID
NCT05647759
Collaborator
Center for Clinical and Translational Research (CCTR) (Other), Lexington Regional Health Center (Other), CHI Good Samaritan (Other)
10
1
19
0.5

Study Details

Study Description

Brief Summary

This study builds on the tested and refined HEART Camp intervention which has been shown to improve long-term adherence to exercise in individuals diagnosed with heart failure. HEART Camp Connect enhances HEART Camp by delivering the coaching via videoconference and providing access to hospital-based exercise facilities and online exercise programming. This study is a prospective, single-group, repeated measures feasibility study with 4 data collection points (baseline, 4, 8, and 12 weeks). Study variables including instruments will be collected at baseline, 4, and 8 weeks. Participants will also be asked to participate in a 30-45 minute interview at 12 weeks.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: HEART Camp Connect
N/A

Detailed Description

At Lexington Regional Health Center (LRHC), potential participants will be identified, screened, and approached for participation. Study personnel will obtain informed consent in person in a private room or over the phone facilitated by the University of Nebraska Medical Center (UNMC) electronic consent process. Once consented, participants will complete cardiopulmonary exercise testing (CPET) to guide individual exercise prescriptions and protect against risks associated with exercise. CPET results that preclude safe exercise training (arrhythmia) or those with CPET results indicating cardio-respiratory fitness (females with maximum oxygen consumption ≥ 21ml/kg/min and males with oxygen consumption ≥ 24 ml/kg/min) will be withdrawn from the study.

Study personnel will complete baseline data collection (demographics, survey collection, and 6-minute-walk-test) on all participants at enrollment. The survey instruments have been validated and will be repeated at weeks 4 and 8. Participants will be given instruction on the use of the Actigraph, Polar Watch and chest strap, and Activity/Exercise Diary. The Actigraph will be worn for 7 consecutive days at baseline, week 4, and week 8. Participants will be asked to record daily activity/exercise in their diary for the entirety of the 12-week study and will be shared weekly with their coach. Participants will wear their Polar Watch and chest strap during exercise sessions for heart rate monitoring.

Prior to beginning exercise on their own, participants will complete 6 supervised, monitored sessions in cardiac rehabilitation. During these sessions, participants will be monitored by cardiac rehabilitation staff for adverse events during moderate-intensity aerobic exercise (40-80% of heart rate reserve) and resistance training (10-15 repetitions to volitional fatigue). During these sessions, participants will also receive educational training via videos on topics such as exercising with heart failure, how medications impact exercise, and nutrition. If a participant does not complete the sessions or is deemed unsafe to exercise, he/she will not be eligible to continue in the study.

Participants will be instructed to wear a heart rate monitor (Polar Watch and chest strap) during all exercise sessions and strive to meet a goal of 150 minutes of moderate-intensity exercise per week. Minutes toward adherence goals for the study will be calculated as time spent participating in a moderate-intensity activity and determined by their CPET results and personalized exercise prescription. Participants will be familiar with using heart rate and Rating of Perceived Exertion (RPE) to guide their exercise from their participation in the 6 supervised sessions. The heart rate monitor will be blue-tooth enabled and will require connection to the internet.

Participants will be given the choice to exercise at a hospital-based exercise facility, at home, or as a hybrid approach. If exercising at home, participants will be provided with training plans that will be available online or in hard-copy forms.

Each participant will be given access to an Omaha-based exercise coach that he/she will meet with weekly over Zoom for 30 minutes. Coaches will discuss exercise over the past week including problems, issues, concerns. Goals will be set, reviewed, assessed, and revised each week.

All participants will be given paid access to the Lexington Regional Health Center fitness facility for 8 weeks out of this 12-week study. Weeks 9-12 of the study, participants may elect to self-pay for membership or exercise at home. Exercise diaries will continue to be collected and Polar watch data will be monitored by exercise coaches until the end of this 12-week study. Participants will not meet with their exercise coach during the final 4 weeks. Our rationale for this is that ultimately our goal is for participants to develop self-efficacy, knowledge, and positive attitudes toward exercise that will allow them to adhere to exercise without our intervention. Our hope is that 8 weeks of exercise training and weekly coaching will get them started and they will continue on their own after that.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This study is a prospective, single-group, repeated measures feasibility study.This study is a prospective, single-group, repeated measures feasibility study.
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
If consent is obtained in person, study personnel will be in a private room with both parties masked, eye protection, and social distancing guidelines in place. Baseline data collection will occur in a private room with masks, eye protection, and social distancing guidelines in place. Hospital-based facilities and staff are in compliance with local health department guidance on masks and social distancing.
Primary Purpose:
Other
Official Title:
Rural HEART Camp Connect: A Feasibility Study
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Feasibility of administering Rural HEART Camp Connect [Baseline]

    Feasibility of administering an exercise intervention with the help of virtual exercise coaches to rural patients with heart failure. The feasibility assessment will focus on process, resources, management, and science.

  2. Determine perceptions of Rural HEART Camp connect in study participants [12 weeks]

    Qualitative interviews will explore perceptions of all study procedures, including use of home-based exercise and virtual coaching.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of heart failure with preserved ejection fraction or heart failure (HF) with reduced ejection fraction (Stage C, chronic HF confirmed by echocardiography and clinical evaluation)

  • 19 years of age or older

  • Stable pharmacologic therapy per guidelines for preceding 30 days

  • Able to read and understand English.

Exclusion Criteria:
  • Clinical evidence of decompensated heart failure

  • Unstable angina

  • Myocardial infarction, coronary artery bypass surgery, or biventricular pacemaker less than 6 weeks prior

  • Orthopedic or neuromuscular disorders preventing participating in aerobic exercise

  • Pregnancy

  • Participation in 3 times per week aerobic exercise during the past 6 months

  • Plans to move more than 50 miles from the exercise facility in the next 12 weeks

  • Cardiopulmonary stress test results that preclude safe exercise training (arrhythmia) or cardiorespiratory fitness indicated by females with maximum oxygen consumption ≥ 21ml/kg/min and males with maximum oxygen consumption ≥ 24 ml/kg/min.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Nebraska Medical Center Omaha Nebraska United States 68198-5330

Sponsors and Collaborators

  • University of Nebraska
  • Center for Clinical and Translational Research (CCTR)
  • Lexington Regional Health Center
  • CHI Good Samaritan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Windy Alonso, PhD, RN, University of Nebraska
ClinicalTrials.gov Identifier:
NCT05647759
Other Study ID Numbers:
  • 773-20
First Posted:
Dec 12, 2022
Last Update Posted:
Dec 12, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Windy Alonso, PhD, RN, University of Nebraska
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 12, 2022